Countries Australia
Australia’s PrOSPeCT Project Is Sequencing Thousands of Cancer Patients
This March, Australia launched the Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT), which will sequence the genomes of more t...
June 23, 2022 | News
Telix and Invicro Advance AI Partnership
TelixAITM seeks to increase the efficiency and reproducibility of clinicians' imaging assessments using advanced analysis capabilities with an initial...
June 15, 2022 | News
Jubilant Radiopharma Joins Illuccix® Pharmacy Partner Network
The expansion of the distribution network facilitates broader patient access to Illuccix across the country, expanding availability into new regional marke...
June 14, 2022 | News
RAD adds brain tumor technology to portfolio
Sublicensing of promising imaging & therapeutic radiopharmaceutical from leading US university, Case Western Reserve University (CWRU),&nbs...
June 13, 2022 | News
Telix and RefleXion Expand Partnership for Prostate Cancer Treatment
BgRT is the first and only cancer treatment designed to integrate PET technology as part of external-beam radiotherapy delivery. It uses PET tracers a...
June 13, 2022 | News
US FDA Clears IND for Cynata's Phase 2 Clinical Trial of CYP-001 in GvHD
Key Highlights: US FDA has cleared Cynata's IND application for a Phase 2 clinical trial of CYP-001 in patients with aGvHD – a major mil...
May 27, 2022 | News
Medison Pharma strengthening its commercial offering into Australia and New Zealand
Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international mark...
May 24, 2022 | News
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
The Summit will feature insights from leading Novotech experts tapping decades of oncology clinical experience in the APAC region. They include:- Dr. Raman...
May 12, 2022 | News
Inmagene Receives FDA's IND Clearance for OX40 Antagonist
IMG-007 is highly potent at blocking the binding of OX40 to OX40L, thereby reducing OX40L-dependent downstream signaling and cytokine release by T cells. I...
May 03, 2022 | News
Inmagene Receives FDA's IND Clearance for OX40 Antagonist
IMG-007 is highly potent at blocking the binding of OX40 to OX40L, thereby reducing OX40L-dependent downstream signaling and cytokine release by T cells. I...
May 02, 2022 | News
DetectedX and GE Healthcare Enter Mammography Education Partnership to Improve Accuracy and Better Inform Clinical Decisions
Fostering global excellence in diagnostic accuracy, DetectedX and GE Healthcare have entered into an educational partnership to expand access to the Radiol...
April 26, 2022 | News
Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab
Telix Pharmaceuticals Limited (ASX: TLX, "Telix", the "Company") today announces that it has entered into a licence agreement with Eli Lilly and Comp...
April 11, 2022 | News
New very-high-sensitivity rapid antigen test kits hit Australian market
Medriva; https://medriva.com, a leading global manufacturer of COVID-19 testing and vaccination products, announced the Australian availability ...
April 08, 2022 | News
Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark
Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu Assay result of Seegene's decades-long know-how, applies D...
April 07, 2022 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
